telomeres
Telo Genomics Gets CLIA Certification for Clinical Laboratory
The certification enables the Canadian cancer testing firm to offer clinical lab services in the US and to distribute its TeloView prognostic products in the US and elsewhere.
Telo Genomics, Mayo Clinic Collaborate on Multiple Myeloma Clinical Studies
The first phase of the study to evaluate Telo Genomics' telomere analytics as a prognostic solution for multiple myeloma is expected to launch in Q1 2020.
3D Signatures, MDxHealth to Evaluate Prostate Cancer Test
The companies will co-fund a new study of the 3DS technology, and MDxHealth will have the option to exclusively license the telomere-based test.
The firm's first assay will be for Hodgkin lymphoma, but a liquid biopsy test for prostate cancer has also shown strong predictive power in initial validation data.